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Researchers should consider five questions before starting a stepped wedge trial.
Why are you planning one? Researchers sometimes think that stepped wedge trials are useful when there is little
doubt about the benefit of the intervention being tested. However, if the primary reason for an intervention is to
measure its effect, without equipoise there is no ethical justification for delaying implementation in some clusters.
By contrast, if you are undertaking pragmatic research, where the primary reason for rolling out the intervention is
for it to exert its benefits, and if phased implementation is inevitable, a stepped wedge trial is a valid option and
provides better evidence than most non-randomized evaluations.
What design will you use? Two common stepped wedge designs are based on the recruitment of a closed or open
cohort. In both, individuals may experience both control and intervention conditions and you should be concerned
about carry-over effects. In a third, continuous-recruitment, short-exposure design, individuals are recruited as they
become eligible and experience either control or intervention condition, but not both.
How will you conduct the primary analysis? In stepped wedge trials, control of confounding factors through secular
variation is essential. ‘Vertical’ approaches preserve randomization and compare outcomes between randomized
groups within periods. ‘Horizontal’ approaches compare outcomes before and after crossover to the intervention
condition. Most analysis models used in practice combine both types of comparison. The appropriate analytic
strategy should be considered on a case-by-case basis.
How large will your trial be? Standard sample size calculations for cluster randomized trials do not accommodate the
specific features of stepped wedge trials. Methods exist for many stepped wedge designs, but simulation-based
calculations provide the greatest flexibility. In some scenarios, such as when the intracluster correlation coefficient is
moderate or high, or the cluster size is large, a stepped wedge trial may require fewer clusters than a parallel cluster trial.
How will you report your trial? Stepped wedge trials are currently challenging to report using CONSORT principles.
Researchers should consider how to demonstrate balance achieved by randomization and how to describe trends for
outcomes in both intervention and control clusters.
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In stepped wedge cluster randomized trials (SWTs), clusters
are randomly allocated to crossover to the intervention at
different time-points and all clusters receive the interven-
tion eventually [1, 2]. Stepped wedge trials are used in both
explanatory and pragmatic research [3, 4]. In explanatory
research, the intervention is primarily implemented to* Correspondence: james.hargreaves@lshtm.ac.uk
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intervention further are made after research is completed.
By contrast, in pragmatic research, the intervention is pri-
marily offered in order for it to exert its expected benefits;
research insights are a secondary gain. In such situations,
decisions about where and when the intervention is to be
delivered will be influenced by practical concerns, although
randomization may be feasible. In explanatory research, an
SWT may be considered instead of a conventional cluster
randomized trial, if resources are insufficient to offer the
intervention to all intervention clusters simultaneously. Inss article distributed under the terms of the Creative Commons Attribution
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for logistical reasons. Stepped wedge trials do offer a rigor-
ous research option when phased implementation is
planned, but they also present challenges [5–8].
Recent debates about Phase II and III trials of candidate
Ebola vaccines highlight some of these challenges [9].
Some researchers argued that a SWT should be used ra-
ther than a parallel trial, as this would be more appropri-
ate to study the effectiveness of vaccines already tested for
safety and immunogenicity in Phase I trials. Others argued
that the safety of the vaccine should be reassessed, and
that a SWT design would make it more difficult to deter-
mine effectiveness because of difficulties in accounting for
time-varying confounding caused by changes in disease in-
cidence and preventive behaviours [10].
These debates and the recent methodological literature
highlight how much remains to be done on the uses,
ethics, conduct and analysis of SWTs. In this commen-
tary, we reflect on findings from articles presented in
this issue of Trials, by considering five questions for re-
searchers to consider if they are planning a SWT.
Why are you planning a SWT?
Interviews with researchers suggest that the primary rea-
sons they choose a SWT design relate to logistic or eth-
ical considerations rather than design advantages [11].
Three scenarios may have particular resonance for re-
searchers thinking of conducting an SWT.
Are you an explanatory researcher thinking that
phased roll-out is the only practical way to implement
your study? We advise caution. Phased implementation
attracts researchers to SWT but brings its own chal-
lenges. It can require repeated training activities, sus-
tained engagement with clusters in the control arm to
avoid drop-out, and increasing workload for intervention
teams over time as more clusters initiate the interven-
tion [11]. Further, it may be difficult to ensure that a
randomly determined roll-out is adhered to. These logistic
constraints should be considered before deciding whether
a SWT is the best option. Other variants of the cluster
randomized trial design can accommodate phased imple-
mentation and should be considered [6].
Alternatively, are you an explanatory researcher arguing
that a SWT is appropriate, whereas a parallel cluster ran-
domized trial is not, because the potential benefit of the in-
terventions seems clear, at least in principle, and the
research question turns on efficacy or effectiveness in a cer-
tain context? If so, you may need to think again. Planning a
SWT requires you to be clear about where the equipoise
lies [12, 13]. It may lie in uncertainty about the effectiveness
of an intervention whose efficacy has been established, or
in uncertainty about potential efficacy in a setting that is
substantially different from those of previous studies. How-
ever, the equipoise has to lie somewhere because without itthere is no ethical justification for delaying implementation
in some clusters [11].
Finally, are you a pragmatic researcher interested in the
effects of an intervention that is being rolled out, but
about which there remains much to learn in a real world
setting, in a new context, or on outcomes for which it has
not previously been considered? Are you working along-
side implementers who say that a SWT is an option? We
think that such situations offer the most convincing justi-
fications for conducting a SWT. We reiterate that modified
cluster randomized trial designs can also accommodate
phased implementation [6], but in cases where a well-
conducted SWT is undertaken, the design will usually lead
to much stronger evidence than observational studies [14].
What SWT design will you use?
Stepped wedge trials encompass a wide range of specific
designs [15]. Copas et al. [14] outline in this series, for the
first time, a comprehensive taxonomy in which SWTs are
characterized on the basis of (i) when individual-level ex-
posure to the treatment condition starts, (ii) the duration
of exposure, and (iii) the approach to outcome measure-
ment. This taxonomy incorporates two classic designs that
currently appear in the literature: those based on a closed
or an open cohort of participants. These designs can po-
tentially suffer from carry-over effects when many
individuals experience both control and intervention
conditions. We also define a third commonly used design:
the continuous-recruitment, short-exposure design is cur-
rently neglected in the methodological SWT literature,
despite being the approach used in the first SWT con-
ducted in the Gambia [2]. Copas et al. [14] discuss the dif-
ferent issues that affect the strengths and weaknesses of
these designs; future methodological research is needed to
flesh out these differences.
Two design decisions are specific to SWTs: the number
of crossover points – times when clusters change from con-
trol to intervention conditions – at which the intervention
is introduced, and the times between successive crossover
points. Both decisions may be influenced by research, im-
plementation or logistic concerns. Commonly, clusters are
divided into groups, which are then randomly allocated to
the time point at which the intervention is implemented, so
that the number of groups equals the number of crossover
points in the trial. Researchers need to consider the impact
of different decisions on study power [5, 7] and overall
study length [14]. Sometimes there is a lag between the
time that a cluster crosses over and the time that the inter-
vention can affect the outcome in individuals. In an open
or closed cohort, SWT measures may be taken just before
every crossover point. In this case. the time between suc-
cessive crossover points can be chosen to be longer than
the length of the lag period [7, 16], though as an alternative,
incomplete SWTs can be used with shorter time between
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lection during each cluster’s lag period.
What analysis strategy will you use?
In SWTs, outcome data under intervention conditions will
be, on average, collected later than control data. Ensuring
that the primary measure of the intervention effect is un-
confounded by secular change in the outcome variable is,
therefore, a key challenge. A range of approaches are avail-
able [7, 16–18]. Conceptually, these approaches can be
thought of in two ways. Vertical approaches compare out-
comes between clusters randomly assigned to either the
intervention or the control condition within the time be-
tween successive crossover points. Horizontal approaches
compare outcomes before and after crossing over from
the control to the intervention condition [7]. In practice,
most SWTs are analyzed with cluster-random effects
models and adjusted for time, thereby incorporating infor-
mation from both vertical and horizontal comparisons in
the intervention effect [16]. An analysis conditional on
time should be most robust to secular trends, but appro-
priate models are not easily available for all types of out-
come or SWT design. Time-varying confounding can
create a situation in which intervention effect estimates
from horizontal and vertical approaches differ [19]. For
this reason, in this collection Davey et al. suggest that ran-
domized, vertical intervention effect estimates within ap-
propriate periods should be presented and compared with
the overall intervention effect from the model [16]. There
remains a need for future research on vertical approaches
to the analysis of SWTs, and guidance on the conditions
under which caution should be taken in interpreting
mixed vertical and horizontal analyses.
Finally, many SWTs include in their primary analysis
data collected before or after all clusters have crossed over
to the intervention condition [15]. Sometimes these data
are collected from much longer periods than the time be-
tween crossover points during the trial. However, without
clusters in both conditions, it is difficult to untangle the
secular trends from the intervention effect using such data.
These data can indirectly provide some information on the
intervention effect through assumptions made concerning
secular trends and the correlation of data within clusters
over time, but these assumptions might become less realis-
tic as greater periods before or after roll-out are incorpo-
rated and bias could arise in analysis. We recommend that
primary analyses be based mainly on data from those ex-
posed to the intervention or control while clusters are in
both conditions, supplemented, if available, only by data
from immediately before or after the roll-out period [14].
How big should your trial be?
Standard sample size calculations for individually and
cluster randomized trials fail to accommodate thespecific features of SWTs. Calculations for SWTs using a
design effect or other method have been published and are
suitable for some SWTs [7, 20], and a Stata routine is avail-
able for some designs [21]. Baio et al. [22] provide in this
series examples of simulation-based calculations. Though
potentially more complex to implement than current
methods, these provide the greatest flexibility to accommo-
date the full range of SWT designs and analysis models.
In some situations, for example when the intracluster
correlation coefficient is moderate or high, or the cluster
size is large, SWTs analyzed using mixed models, such
as those already described, provide more power than
parallel cluster randomized trials with the same number
of clusters and cluster size [5, 22, 23].
How will you report the design and profile of
your trial?
There are currently no CONSORT guidelines for report-
ing SWTs, though work is underway to produce them.
Copas et al. [14] provide a diagram outlining key design
dimensions that should be reported for all SWTs. Davey
et al. [16] identify how trial results are reported in
recent SWTs, noting limitations and substantial hetero-
geneity in current practice. Researchers should consider
how they will assess and report balance between control
and intervention conditions, since all clusters experience
both conditions. Some, but not all, of the papers we
reviewed attempted to formally assess balance between
randomized groups [24–29]. We also recommend that
SWT reports should describe trends in outcomes for
both the intervention and control clusters over the study
period. Again, some, but not all, of the trials we reviewed
provide examples of such reporting [24–26].
Conclusion
An ethically sound, well-designed and conducted SWT
with appropriate analysis can provide strong evidence of
the effects of an intervention. Such evidence should be
considered of higher quality than that arising from non-
randomized studies. The potential for SWTs to be de-
ployed in pragmatic public health evaluation and to
increase the quality and volume of evidence available to
guide public health decisions means that their appropri-
ate use should be encouraged.
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